drugset / Trial / NCT05878119
Effects of MIB-626 With and Without A High-Intensity Multi-Dimensional Exercise Training Program
RandomizedParallel-groupQuadruple-blindTreatment
Summary
A single-center, randomized, placebo-controlled study in community dwelling, healthy, regularly exercising, highly physically fit men and women, 19 to 40 years. Eligible participants will be randomized to receive either 1000 mg NMN or placebo twice daily for 10 weeks.
Timeline
- Start
- 2023-10-25
- Primary completion
- 2025-06-17
- Completion
- 2025-08-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | MIB-626 | Unknown | 1000 mg | — |
Indications
No indication recorded.